Figure 3From: Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study Changes in calprotectin levels after two weeks’ treatment with irsogladine or omeprazole (mean ± SD). Back to article page